Announcement of Fangsheng Pharmaceutical on the receipt of a notice of acceptance of drug registration by its wholly-owned subsidiary

SZSI · Sep 19

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.